Print

Evaluation and Continuous Improvement

  1. What's It All About?
  2. Who is Responsible?
  3. Tell Me More.

The goal of the Evaluation and Continuous Improvement (ECI) component is to provide credible and timely feedback on the growth and impact of the project on clinical and translational science research and training across GHUCCTS, as a whole, and specifically within each of the core components. This will be achieved through the collection of processes and outcome data that assess the extent to which the project is achieving its aims of (a) increasing the number of clinical and translational researchers and studies, (b) facilitating collaborative research across institutions, (c) increasing quantity and quality of community-based translational research, (d) increasing the cultural competencies of translational researchers, (e) developing and applying new technologies in translational science, and (f) contributing to ethical and health service perspectives. Tracking and performance data will be based on identified metrics as articulated in the module’s continuous improvement plans.

The ECI component will undertake a mixed-methods approach to evaluation design and utilize a variety of data collection (e.g., web data, interviews, administrative records, community surveys) and reporting methods. Additionally, the ECI component will actively participate in NIH’s national CTSA Common Metrics (CM) initiative and other tracking and evaluation activities. All ECI activities will be carried out in accordance with the American Evaluation Association’s Guiding Principles for Evaluators and the Joint Committee’s Program Evaluation Standards.